Evidence is growing that protease-activated receptor-2 (PAR-2) plays a key role in epithelial inflammation. We hypothesized here that PAR-2 plays a central role in epidermal permeability barrier homeostasis by mediating signaling from serine proteases (SP) in the stratum corneum (SC). Since the SC contains tryptic- and chymotryptic-like activity, we assessed the influence of SP activation/inhibition on barrier function. Acute barrier disruption increases SP activity and blockade by topical SP inhibitors (SPI) accelerates barrier recovery after acute abrogation. This improvement in barrier function is due to accelerated lamellar body (LB) secretion. Since tryptic SP signal certain downstream responses through PAR-2, we assessed its potential role in mediating the negative effects of SP on permeability barrier. Firstly, PAR-2 is expressed in the outer nucleated layers of the epidermis and most specifically under basal condition to the lipid raft (LR) domains. Secondly, tape stripping-induced barrier abrogation provokes PAR-2 activation, as shown by receptor internalization (i.e. receptor movement from LR to cytolpasmic domains). Thirdly, topical applications of PAR-2 agonist peptide, SLIGRL, delay permeability barrier recovery and inhibit LB secretion, while, conversely, PAR-2 knockout mice display accelerated barrier recovery kinetics and enhanced LB secretion, paralleled by increased LR formation and caveolin-1 expression. These results demonstrate first, the importance of SP/SPI balance for normal permeability barrier homeostasis, and second, they identify PAR-2 as a novel signaling mechanism of permeability barrier, that is, of response linked to LB secretion.
|Number of pages||13|
|Journal||Journal of Investigative Dermatology|
|Publication status||Published - 2006 Sept|
Bibliographical noteFunding Information:
Ms Jerelyn Magnusson and Ms Joan Wakefield provided excellent editorial assistance. These studies were supported by NIH grants AR19098, HD29706, AI059311, AR049932, AR39448 (PP), the Medical Research Service, Department of Veterans Affairs; the Free University of Brussels (OZR grant 1006, Gepts Funds), and the Flemish Funds for Scientific Research (FWO306). Jean-Pierre Hachem was a recipient of fellowships from the René Touraine Foundation and the Flemish Funds for Scientific Research.
All Science Journal Classification (ASJC) codes
- Molecular Biology
- Cell Biology